In vitro sensitivity testing of human bladder cancers and cell lines to TP-40, a hybrid protein with selective targeting and cytotoxicity

Keyphrases

• Epidermal Growth Factor Receptor 100%
• Human Bladder Cancer 100%
• Sensitivity Test 100%
• Selective Targeting 100%
• Epidermal Growth Factor 100%
• Hybrid Protein 100%
• Selective Cytotoxicity 100%
• Bladder Cancer Cells 100%
• In Vitro Sensitivity 100%
• Tumor 50%
• Transforming Growth Factor-β 50%
• Pre-exposure 50%
• Bladder Cancer 50%
• Fusion Protein 50%
• Urinary Bladder 50%
• Well-differentiated 50%
• Clonogenic Assay 50%
• Gene Amplification 50%
• Bladder Tumor 50%
• Bladder Cancer Cell Lines 50%
• Pseudomonas Exotoxin 50%
• Recombinant Technology 50%
• Hybrid Fusion 50%
• Vesicant Agent 50%

Medicine and Dentistry

• In Vitro 100%
• Bladder Cancer 100%
• Chimeric Protein 100%
• Cell Line 100%
• Cytotoxicity 100%
• Epidermal Growth Factor Receptor 66%
• Epidermal Growth Factor 66%
• Neoplasm 33%
• Receptor 33%
• Clonogenic Assay 33%
• Bladder Cancer Cell Line 33%
• Bladder Tumor 33%
• Transforming Growth Factor Alpha 33%
• Gene Amplification 33%
• Pseudomonas Exotoxin 33%

Pharmacology, Toxicology and Pharmaceutical Science

• Bladder Cancer 100%
• Chimeric Protein 100%
• Cytotoxicity 100%
• Epidermal Growth Factor 50%
• Epidermal Growth Factor Receptor 50%
• Receptor 25%
• Bladder Tumor 25%
• Pseudomonas Exotoxin 25%
• Transforming Growth Factor Alpha 25%
• Neoplasm 25%